scholarly journals Assignment of the group A rotavirus NSP4 gene into genotypes using a hemi-nested multiplex PCR assay: a rapid and reproducible assay for strain surveillance studies

2009 ◽  
Vol 58 (3) ◽  
pp. 303-311 ◽  
Author(s):  
Krisztián Bányai ◽  
Ágnes Bogdán ◽  
György Szücs ◽  
Serenella Arista ◽  
Simona De Grazia ◽  
...  
Keyword(s):  
Vaccine Development ◽  
Interspecies Transmission ◽  
Reference Laboratory ◽  
Nsp4 Gene ◽  
Structural Protein ◽  
Multiplex Pcr Assay ◽  
Human Rotavirus ◽  
Group A ◽  
P Type ◽  
Animal Strains

The rotavirus non-structural protein NSP4 has been implicated in a number of biological functions during the rotavirus cellular cycle and pathogenesis, and has been addressed as a target for vaccine development. The NSP4 gene has been classified into six genotypes (A–F). A semi-nested triplex PCR was developed for genotyping the major human NSP4 genotypes (A–C), which are common in human rotavirus strains but are also shared among most mammalian rotavirus strains. A total of 192 previously characterized human strains representing numerous G and P type specificities (such as G1P[8], G1P[4], G2P[4], G3P[3], G3P[8], G3P[9], G4P[6], G4P[8], G6P[4], G6P[9], G6P[14], G8P[10], G8P[14], G9P[8], G9P[11], G10P[11], G12P[6] and G12P[8]) were tested for NSP4 specificity by the collaborating laboratories. An additional 35 animal strains, including the reference laboratory strains SA11 (simian, G3P[2]), NCDV (bovine, G6P[1]), K9 and CU-1 (canine, G3P[3]), together with 31 field isolates (canine, G3P[3]; feline, G3P[9]; porcine, G2P[23], G3P[6], G4P[6], G5P[6], G5P[7], G5P[26], G5P[27], G9P[6] and G9P[7]) were also successfully NSP4-typed. Four human G3P[9] strains and one feline G3P[9] strain were found to possess an NSP4 A genotype, instead of NSP4 C, suggesting a reassortment event between heterologous strains. Routine NSP4 genotyping may help to determine the genomic constellation of rotaviruses of man and livestock, and identify interspecies transmission of heterologous strains.

Characterization of the NSP4 gene of group A human rotavirus G1P[8] strains circulating in Sapporo, Japan from 1987 to 2000

2013 ◽  
Vol 86 (2) ◽  
pp. 354-359 ◽  
Author(s):  
Masatoshi Tatsumi ◽  
Yoshinobu Nagaoka ◽  
Takeshi Tsugawa ◽  
Yuko Yoto ◽  
Tsukasa Hori ◽  
...  
Keyword(s):  
Nsp4 Gene ◽  
Human Rotavirus ◽  
Group A

scholarly journals Molecular characterisation of the NSP4 gene of group A human rotavirus G2P[4] strains circulating in São Paulo, Brazil, from 1994 and 2006 to 2010

2015 ◽  
Vol 110 (6) ◽  
pp. 786-792 ◽  
Author(s):  
Jéssica Wildgrube Bertol ◽  
Maria Clara Duarte Fregolente ◽  
Thabata Alessandra Ramos Caruzo ◽  
Márcio José da Silva ◽  
Veridiana Munford ◽  
...  
Keyword(s):  
Sao Paulo ◽  
Molecular Characterisation ◽  
São Paulo ◽  
Nsp4 Gene ◽  
Human Rotavirus ◽  
Group A

scholarly journals Human, porcine and bovine rotaviruses in Slovenia: evidence of interspecies transmission and genome reassortment

2008 ◽  
Vol 89 (7) ◽  
pp. 1690-1698 ◽  
Author(s):  
Andrej Steyer ◽  
Mateja Poljšak-Prijatelj ◽  
Darja Barlič-Maganja ◽  
Jožica Marin
Keyword(s):  
Amino Acid ◽  
Amino Acid Sequences ◽  
Zoonotic Transmission ◽  
Interspecies Transmission ◽  
Genotype Combination ◽  
Human Rotavirus ◽  
Group A Rotaviruses ◽  
Group A ◽  
Stool Samples ◽  
Genome Reassortment

A surveillance of human, porcine and bovine rotaviruses was carried out in Slovenia in 2004 and 2005. Stool samples were collected from a total of 406 pigs (373 from asymptomatic animals), 132 cattle (126 from asymptomatic animals) and 241 humans (all with diarrhoea), tested for group A rotaviruses using RT-PCR and analysed by sequencing. The aims of the study were to determine the incidence of asymptomatic rotavirus infection in animals, to look for evidence of zoonotic transmission and to detect reassortment among rotaviruses. The rates of asymptomatic shedding of rotaviruses in pigs and cattle were 18.0 % (67/373) and 4.0 % (5/126), respectively. Evidence for zoonotic transmission was detected in one human rotavirus strain, SI-MB6, with the G3P[6] genotype combination, as the nucleotide and predicted amino acid sequences of the VP6, VP7, VP8* and NSP4 genes of strain SI-MB6 and of porcine strains showed high nucleotide and amino acid sequence identity. Two porcine rotavirus strains carried VP7 of probable human origin, suggesting an interspecies reassortment event in the past.

scholarly journals Human rotavirus infection. Strategies for the vaccinal prevention

2016 ◽  
Vol 61 (4) ◽  
pp. 154-159 ◽  
Author(s):  
K. P. Alekseev ◽  
S. L. Kalnov ◽  
T. V. Grebennikova ◽  
T. I. Aliper
Keyword(s):  
Developing Countries ◽  
Interspecies Transmission ◽  
Animal Origin ◽  
Rotavirus Infection ◽  
China And India ◽  
Pentavalent Vaccine ◽  
Human Rotavirus ◽  
The World ◽  
Group A ◽  
The Cost

Rotavirus was first isolated in 1973 in Australia from children with diarrhea. Hundreds of thousands of children die annually in developing countries from this virus with the mortality peaks in the most impoverished among them. According to wHo, rotavirus infection claims about 440 thousands children lives each year, being third in the mortality rate after pneumonia and malaria. Rotavirus is widely spread throughout the world and by the age of five years almost every child encountered this pathogen at least once. Rotavirus has a high genetic and antigenic diversity. The most important for humans is the group A rotavirus, and the most common by far genotypes are G1P [8], G2P [4], G3P [8], G4P [8], G9P [8], and to a lesser extent G12P [8]. There are three gene constellations described in rotavirus designated Wa, Ds-1, and Au-1. It is believed that they originated from rotaviruses of pigs, cattle, dogs, and cats, respectively. Cases of rotavirus interspecies transmission from animal to humans were reported. The first vaccines against rotavirus infection were based on naturally attenuated virus of the animal origin. Their efficiency, especially in developing countries, was inadequate, but today China and India use vaccines based on animal rotaviruses. Using the method of gene reassortation with the cattle rotavirus WC3 as a backbone, pentavalent vaccine against most common human rotavirus serotypes was developed and now successfully used as RotaTeq. The ability of rotavirus to protect against heterologous isolates was taken into account in the development of other vaccine, Rotarix, created on the basis of rotavirus genotype G1P1A [8]. The efficacy of these vaccines in developing countries is significantly reduced (51%), the cost of a dose is high, and so the search for more effective, safe, and inexpensive vaccines against rotavirus continues around the world.

Complete genome analysis of a rare group A rotavirus, G11P[25], isolated from a child in Mumbai, India, reveals interspecies transmission and reassortment with human rotavirus strains

2014 ◽  
Vol 63 (9) ◽  
pp. 1220-1227 ◽  
Author(s):  
Sushmitha A. Shetty ◽  
Meenakshi Mathur ◽  
Jagadish M. Deshpande
Keyword(s):  
Complete Genome ◽  
Interspecies Transmission ◽  
Genotype Combination ◽  
Human Rotavirus ◽  
Genotype Constellation ◽  
Group A ◽  
Vp6 Gene ◽  
Gene Reassortment ◽  
Complete Genome Analysis ◽  
Rare Group

Hospital-based rotavirus surveillance was carried out in Mumbai during 2005–2009. An isolate (B08299) with a rare genotype combination (G11P[25]) was detected. The present study was undertaken to characterize the complete genome of the isolate. B08299 exhibited a G11–P[25]–I12–R1–C1–M1–A1–N1–T1–E1–H1 genotype constellation. Phylogenetic analysis of the 11 gene segments of B08299 revealed that the VP2 and NSP5 genes of B08299 had a human origin, while the VP6 gene represented an I12 genotype of obscure origin. The remaining six genes formed a lineage distinct from human and porcine rotaviruses within genotype 1. Analysis of the structural and non-structural genes suggested that B08299 has evolved by gene reassortment. Our findings provide further evidence that interspecies transmission is an important mechanism involved in the evolution and genetic diversity of human rotaviruses in nature.

scholarly journals Molecular Epidemiology of Group A Streptococcus Infections in The Gambia

Vaccines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 124
Author(s):  
Sona Jabang ◽  
Annette Erhart ◽  
Saffiatou Darboe ◽  
Aru-Kumba Baldeh ◽  
Valerie Delforge ◽  
...  
Keyword(s):  
Molecular Epidemiology ◽  
Vaccine Development ◽  
Group A Streptococcus ◽  
Epidemiological Data ◽  
The Gambia ◽  
Strain Diversity ◽  
Group A ◽  
Considerable Strain

Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We characterized the emm-types and emm-clusters of 433 stored clinical GAS isolates from The Gambia collected between 2004 and 2018. To reduce the potential for strain mistyping, we used a newly published primer for emm-typing. There was considerable strain diversity, highlighting the need for vaccine development offering broad strain protection.

scholarly journals Development of RT-multiplex PCR Assay for Detection of Adenovirus and Group A and C Rotaviruses in Diarrheal Fecal Specimens from Children in China

2004 ◽  
Vol 78 (8) ◽  
pp. 699-709 ◽  
Author(s):  
Hainian YAN ◽  
Tuan Anh NGUYEN ◽  
Tung Gia PHAN ◽  
Shoko OKITSU ◽  
Yan LI ◽  
...  
Keyword(s):  
Multiplex Pcr ◽  
Pcr Assay ◽  
Multiplex Pcr Assay ◽  
Group A

scholarly journals Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013

2015 ◽  
Vol 54 (1) ◽  
pp. 134-141 ◽  
Author(s):  
Karen Rudolph ◽  
Michael G. Bruce ◽  
Dana Bruden ◽  
Tammy Zulz ◽  
Alisa Reasonover ◽  
...  
Keyword(s):  
Vaccine Development ◽  
Case Fatality ◽  
Invasive Disease ◽  
Population Based ◽  
The Arctic ◽  
Surveillance Program ◽  
Bacterial Disease ◽  
Invasive Group ◽  
Laboratory Surveillance ◽  
Group A

The Arctic Investigations Program (AIP) began surveillance for invasive group A streptococcal (GAS) infections in Alaska in 2000 as part of the invasive bacterial diseases population-based laboratory surveillance program. Between 2001 and 2013, there were 516 cases of GAS infection reported, for an overall annual incidence of 5.8 cases per 100,000 persons with 56 deaths (case fatality rate, 10.7%). Of the 516 confirmed cases of invasive GAS infection, 422 (82%) had isolates available for laboratory analysis. All isolates were susceptible to penicillin, cefotaxime, and levofloxacin. Resistance to tetracycline, erythromycin, and clindamycin was seen in 11% (n= 8), 5.8% (n= 20), and 1.2% (n= 4) of the isolates, respectively. A total of 51emmtypes were identified, of whichemm1 (11.1%) was the most prevalent, followed byemm82 (8.8%),emm49 (7.8%),emm12 andemm3 (6.6% each),emm89 (6.2%),emm108 (5.5%),emm28 (4.7%),emm92 (4%), andemm41 (3.8%). The five most commonemmtypes accounted for 41% of isolates. Theemmtypes in the proposed 26-valent and 30-valent vaccines accounted for 56% and 78% of all cases, respectively. GAS remains an important cause of invasive bacterial disease in Alaska. Continued surveillance of GAS infections will help improve understanding of the epidemiology of invasive disease, with an impact on disease control, notification of outbreaks, and vaccine development.

scholarly journals Capsid Assembly is Regulated by Amino Acid Residues Asparagine 47 and 48 in The VP2 Protein of Porcine Parvovirus

2020 ◽  
Author(s):  
Jucai Wang ◽  
Yunchao Liu ◽  
Yumei Chen ◽  
Teng Zhang ◽  
Aiping Wang ◽  
...  
Keyword(s):  
Amino Acids ◽  
Amino Acid ◽  
Vaccine Development ◽  
Acid Sites ◽  
Site Directed Mutagenesis ◽  
Porcine Parvovirus ◽  
Capsid Assembly ◽  
Structural Protein ◽  
Native Page ◽  
Vp2 Protein

Abstract Background: Porcine parvovirus (PPV) is a major cause of reproductive failure in swine, and has caused huge losses throughout the world. Viral protein 2 (VP2) of PPV is a major structural protein that can self-assemble into virus-like particles (VLP) with hemagglutination (HA) activity. In order to identify the essential residues involved in the mechanism of capsid assembly and to further understand the function of HA, we analyzed a series of deletion mutants and site-directed mutations within the N-terminal of VP2 in the Escherichia coli (E. coli) system. Results: Our results showed that deletion of first 47 amino acids from the N-terminal of VP2 protein did not affect capsid assembly, and further truncation to residue 48 Asparagine (Asn, N) caused detrimental effects. Site-directed mutagenesis experiments demonstrated that residue 47Asn reduced the assembly efficiency of PPV VLP, while residue 48Asn destroyed the stability, hemagglutination, and self-assembly characteristics of the PPV VP2 protein. These findings indicated that the residues 47Asn and 48Asn are important amino acid sites to capsid assembly and HA activity. Results from Native PAGE inferred that macromolecular polymers were critical intermediates of the VP2 protein during the capsid assembly process. Site-directed mutation at 48Asn did not affect the association of monomers to form into oligomers, but destroyed the ability of oligomers to assemble into macromolecular particles, influencing both capsid assembly and HA activity. Conclusions: These results demonstrated that PPV capsid assembly is a complex process that is regulated by amino acids 47Asn and 48Asn, which are located at the N-terminal of VP2 and closely related to the association of macromolecular particles. Our findings provide valuable information on the mechanisms of PPV capsid assembly and the possibility of chimeric VLP vaccine development by replacing as much as 47 amino acids at the N-terminal of VP2 protein.

Sign in / Sign up

Export Citation Format

Share Document